The Race to Build the Next Generation of Weight Loss Pills Is Heating Up

The race is heating up among pharmaceutical companies to develop oral versions of GLP-1 drugs—the weight loss medications that exploded in popularity over recent years. According to io9, several drug makers are working on pills that would deliver the same active compounds as injectable versions like Ozempic and Wegovy. The shift could make these medications more accessible and easier for patients who'd rather swallow a pill than inject themselves.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton